Photobiomodulation Can Prevent Medication-Related Osteonecrosis of the Jaw Formation in Tooth Extraction Site of Rat Model

被引:1
|
作者
Chegini, Leila [1 ]
Bastami, Farshid [2 ]
Mashhadi-Abbas, Fatemeh [3 ]
Chegini, Reihane [4 ]
Hadadi-Ahangarkolaee, Zahra [1 ]
Fekrazad, Reza [5 ,6 ,7 ]
Dehaki, Mehrzad Gholampour [7 ]
机构
[1] AJA Univ Med Sci, Sch Med, Internal Med Dept, Tehran, Iran
[2] Shahid Beheshti Univ Med Sci, Res Inst Dent Sci, Dent Res Ctr, Sch Dent,Oral & Maxillofacial Surg Dept, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Sch Dent, Oral & Maxillofacial Pathol Dept, Tehran, Iran
[4] Iran Univ Med Sci, Sch Med, Med Pathol Dept, Tehran, Iran
[5] AJA Univ Med Sci, Radiat Sci Res Ctr, Tehran, Iran
[6] Universal Sci Educ & Res Network USERN, Int Network Photo Med & Photo Dynam Therapy INPMPD, Tehran, Iran
[7] AJA Univ Med Sci, Sch Med, Endocrinol Dept, Tehran 1946883893, Iran
关键词
photobiomodulation; medication-related osteonecrosis of the jaw; MRONJ; zoledronic acid; rat model; wound healing; BISPHOSPHONATE-RELATED OSTEONECROSIS; LEVEL LASER THERAPY; HUMAN GINGIVAL FIBROBLASTS; ZOLEDRONIC ACID; IN-VITRO; SURGICAL-TREATMENT; CANCER-PATIENTS; RISK-FACTORS; OSTEOBLASTS; CELLS;
D O I
10.1089/photob.2023.0135
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: This study aims to explore the preventive potential of photobiomodulation (PBM) in bisphosphonate-related osteonecrosis of the jaw (BRONJ) using a rat model.Methods: An experimental rat model was established, exposing rats to zoledronic acid (ZA), a primary risk factor for BRONJ. An 810 nm diode laser was applied with parameters of 0.33 W/cm2 power density and 10 J/cm2 energy density for 30 sec. PBM was initiated 1 day pre-extraction and continued for 2 weeks. The impact of PBM on wound healing in both soft and hard tissues was evaluated post tooth extraction.Results: ZA exposure hindered wound healing in both soft and hard tissues after tooth extraction. PBM intervention effectively mitigated the adverse effects of ZA, promoting healing processes in both tissue types. This suggests the potential of PBM as a preventive strategy for BRONJ in patients on long-term bisphosphonate treatment. Moreover, PBM exhibited enhanced wound healing in normal rats, indicating its broader applicability beyond BRONJ cases.Conclusions: PBM shows promise in preventing and improving wound healing in BRONJ and normal cases. These findings underscore the significance of optimizing PBM parameters and suggest its potential clinical relevance as a preventive intervention for BRONJ and a promoter of wound healing.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 50 条
  • [31] Medication-related osteonecrosis of the jaw - Personal comments
    Pitak-Arnnop, Poramate
    AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2018, 39 (06) : 802 - 802
  • [32] Interventions for managing medication-related osteonecrosis of the jaw
    Beth-Tasdogan, Natalie H.
    Mayer, Benjamin
    Hussein, Heba
    Zolk, Oliver
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (10):
  • [33] Medication-related osteonecrosis of the jaw: A literature review
    Kuroshima, Shinichiro
    Sasaki, Muneteru
    Sawase, Takashi
    JOURNAL OF ORAL BIOSCIENCES, 2019, 61 (02) : 99 - 104
  • [34] Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
    Roato, Ilaria
    Mauceri, Rodolfo
    Notaro, Vincenzo
    Genova, Tullio
    Fusco, Vittorio
    Mussano, Federico
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (09)
  • [35] Prognostic factors of the medication-related osteonecrosis of the jaw
    Szentpeteri Szofia
    Restar Laszlo
    Nemeth Zsolt
    Vaszilko Mihaly
    ORVOSI HETILAP, 2020, 161 (08) : 283 - 289
  • [36] Bisphosphonate and Medication-Related Osteonecrosis of the Jaw: A Review
    Muecke, Thomas
    Krestan, Christian R.
    Mitchell, David A.
    Kirschke, Jan S.
    Wutzl, Arno
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2016, 20 (03) : 305 - 314
  • [37] Necrotizing Fasciitis with Medication-related Osteonecrosis of the Jaw
    Ishibashi, Hiroki
    Sasahara, Teppei
    Katagiri, Oh
    Yamada, Tetsuhisa
    INTERNAL MEDICINE, 2024, 63 (06) : 887 - 888
  • [38] Interventions for managing medication-related osteonecrosis of the jaw
    Beth-Tasdogan, Natalie H.
    Mayer, Benjamin
    Hussein, Heba
    Zolk, Oliver
    Peter, Jens-Uwe
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (07):
  • [39] Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw
    Ruggiero, Salvatore L.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2015, 27 (04) : 479 - +
  • [40] Medication-related osteonecrosis of the jaw related to epacadostat and pembrolizumab
    Decaux, J.
    Magremanne, M.
    JOURNAL OF STOMATOLOGY ORAL AND MAXILLOFACIAL SURGERY, 2020, 121 (06) : 740 - 742